Micafungin Intravenous (IV) Powder bulk supplier for pharma manufacturers

Micafungin Intravenous (Iv) Powder 50 mg, 100 mg/vial Suppliers & Bulk Manufacturers

Available Forms: Intravenous (IV) Powder

Available Strengths: 50 mg, 100 mg/vial

Reference Brands: Mycamine(US & EU)

Micafungin inhibits fungal β-glucan synthase, disrupting cell wall synthesis and causing fungal cell death. It provides broad-spectrum activity against Candida and Aspergillus. Benefits include rapid action, high efficacy, minimal toxicity, and suitability for critically Ill patients, making it vital for treating severe invasive fungal infections.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Micafungin IV powder is approved in the EU and US for treating invasive candidiasis and antifungal prophylaxis. In the EU, Astellas’s Mycamine is regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing standards. In the US, FDA approval is based on extensive clinical data and biosimilarity assessments. Both regions require detailed regulatory dossiers for initial approval and continuous safety monitoring. For expert assistance with pharmaceutical dossiers, regulatory submissions, and compliance, visit PharmaTradz. We facilitate efficient market access for micafungin IV formulations, ensuring adherence to European and American standards for safe, effective antifungal therapy.

Micafungin Intravenous (Iv) Powder — third party manufacturing & bulk supply

Micafungin Intravenous (Iv) Powder 50 mg, 100 mg/vial is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Micafungin Intravenous (Iv) Powder is supplied as Intravenous (IV) Powder — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Micafungin Intravenous (Iv) Powder listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Micafungin Intravenous (Iv) Powder →

Back to Listing

Frequently Asked Questions

Micafungin Intravenous (IV) Powder is listed as Intravenous (IV) Powder in 50 mg, 100 mg/vial. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Micafungin Intravenous (IV) Powder is referenced against Mycamine(US & EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.